0001209191-20-012197.txt : 20200224
0001209191-20-012197.hdr.sgml : 20200224
20200224183833
ACCESSION NUMBER: 0001209191-20-012197
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200224
FILED AS OF DATE: 20200224
DATE AS OF CHANGE: 20200224
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gulfo Adele M.
CENTRAL INDEX KEY: 0001647102
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37929
FILM NUMBER: 20646390
MAIL ADDRESS:
STREET 1: ONE NEENAH CENTER, 4TH FLOOR
STREET 2: P.O. BOX 669
CITY: NEENAH
STATE: WI
ZIP: 54957
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Myovant Sciences Ltd.
CENTRAL INDEX KEY: 0001679082
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: CA
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: SUITE 1, 3RD FLOOR
STREET 2: 11-12 ST. JAMES SQUARE
CITY: LONDON
STATE: X0
ZIP: SW1Y 4LB
BUSINESS PHONE: 44(0)207 400 3347
MAIL ADDRESS:
STREET 1: SUITE 1, 3RD FLOOR
STREET 2: 11-12 ST. JAMES SQUARE
CITY: LONDON
STATE: X0
ZIP: SW1Y 4LB
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-02-24
0
0001679082
Myovant Sciences Ltd.
MYOV
0001647102
Gulfo Adele M.
C/O MYOVANT SCIENCES INC.
2000 SIERRA POINT PARKWAY, 9TH FLOOR
BRISBANE
CA
94005
1
0
0
0
Stock Option (Right to Buy)
11.17
2020-02-24
4
A
0
45000
0.00
A
2030-02-23
Common Stock
45000
45000
D
1/3rd of the shares underlying the option vest and become exercisable on February 24, 2021, with the balance of the shares vesting in eight equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer through the vesting date.
/s/ Matthew Lang, Attorney-in-fact
2020-02-24